1. Home
  2. TWST vs MBIN Comparison

TWST vs MBIN Comparison

Compare TWST & MBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWST
  • MBIN
  • Stock Information
  • Founded
  • TWST 2013
  • MBIN 1990
  • Country
  • TWST United States
  • MBIN United States
  • Employees
  • TWST N/A
  • MBIN N/A
  • Industry
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • MBIN Major Banks
  • Sector
  • TWST Health Care
  • MBIN Finance
  • Exchange
  • TWST Nasdaq
  • MBIN Nasdaq
  • Market Cap
  • TWST 2.3B
  • MBIN 2.0B
  • IPO Year
  • TWST 2018
  • MBIN 2017
  • Fundamental
  • Price
  • TWST $32.61
  • MBIN $31.47
  • Analyst Decision
  • TWST Buy
  • MBIN Buy
  • Analyst Count
  • TWST 10
  • MBIN 3
  • Target Price
  • TWST $49.10
  • MBIN $47.50
  • AVG Volume (30 Days)
  • TWST 1.2M
  • MBIN 180.1K
  • Earning Date
  • TWST 05-05-2025
  • MBIN 04-28-2025
  • Dividend Yield
  • TWST N/A
  • MBIN 1.27%
  • EPS Growth
  • TWST N/A
  • MBIN N/A
  • EPS
  • TWST N/A
  • MBIN 5.44
  • Revenue
  • TWST $347,680,000.00
  • MBIN $621,412,000.00
  • Revenue This Year
  • TWST $22.54
  • MBIN $8.67
  • Revenue Next Year
  • TWST $17.77
  • MBIN $6.70
  • P/E Ratio
  • TWST N/A
  • MBIN $5.77
  • Revenue Growth
  • TWST 25.30
  • MBIN 7.58
  • 52 Week Low
  • TWST $29.76
  • MBIN $30.73
  • 52 Week High
  • TWST $60.90
  • MBIN $53.27
  • Technical
  • Relative Strength Index (RSI)
  • TWST 35.96
  • MBIN 44.06
  • Support Level
  • TWST $31.56
  • MBIN $29.87
  • Resistance Level
  • TWST $42.07
  • MBIN $32.25
  • Average True Range (ATR)
  • TWST 2.54
  • MBIN 1.63
  • MACD
  • TWST -0.56
  • MBIN 0.13
  • Stochastic Oscillator
  • TWST 9.99
  • MBIN 60.81

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

About MBIN Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and Banking segment that provides a wide range of financial products and services to consumers and businesses, including commercial and other consumer loan products.

Share on Social Networks: